Arcutis Biotherapeutics Inc. (ARQT) is priced at $33.50 after the most recent trading session. At the very opening of the session, the stock price was $33.718 and reached a high price of $36.45, prior to closing the session it reached the value of $30.55. The stock touched a low price of $33.31.
Recently in News on April 28, 2021, Arcutis to Present at the 2021 Truist Securities Life Sciences Summit. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a virtual fireside chat during the 2021 Truist Securities Life Sciences Summit taking place May 4-5, 2021. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Arcutis Biotherapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $38.49 on 02/09/21, with the lowest value was $24.25 for the same time period, recorded on 01/27/21.
Arcutis Biotherapeutics Inc. (ARQT) full year performance was 12.72%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arcutis Biotherapeutics Inc. shares are logging -15.94% during the 52-week period from high price, and 91.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $17.51 and $39.85.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1543187 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Arcutis Biotherapeutics Inc. (ARQT) recorded performance in the market was 19.09%, having the revenues showcasing 22.76% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.53B, as it employees total of 54 workers.
Analysts verdict on Arcutis Biotherapeutics Inc. (ARQT)
During the last month, 0 analysts gave the Arcutis Biotherapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 30.35, with a change in the price was noted +7.49. In a similar fashion, Arcutis Biotherapeutics Inc. posted a movement of +28.80% for the period of last 100 days, recording 248,591 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARQT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Arcutis Biotherapeutics Inc. (ARQT): Technical Analysis
Raw Stochastic average of Arcutis Biotherapeutics Inc. in the period of last 50 days is set at 71.24%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 72.25%. In the last 20 days, the company’s Stochastic %K was 72.92% and its Stochastic %D was recorded 73.14%.
Let’s take a glance in the erstwhile performances of Arcutis Biotherapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 19.09%. Additionally, trading for the stock in the period of the last six months notably improved by 66.42%, alongside a boost of 12.72% for the period of the last 12 months. The shares increased approximately by 15.64% in the 7-day charts and went down by 15.80% in the period of the last 30 days. Common stock shares were driven by 22.76% during last recorded quarter.